-

Thermo Fisher Scientific Recognized for Contract Manufacturing Leadership

Pharma and biotech customers distinguish excellence in capabilities, expertise, quality, compatibility, reliability and service

WALTHAM, Mass.--(BUSINESS WIRE)--For the third consecutive year, Thermo Fisher Scientific’s pharma and biopharma customers recognized its contract manufacturing leadership in all six categories of the 11th Annual CMO Leadership awards.

The annual honors, presented by Life Science Leader and Outsourced Pharma, spotlight excellence in Capabilities, Expertise, Quality, Compatibility, Reliability and Service. The customers evaluated 86 companies across 23 performance metrics.

"Patients worldwide need treatments sooner than ever so we need to exceed our customers’ expectations every day,” said Mike Shafer, senior vice president and president, pharma services, Thermo Fisher Scientific. “We’re grateful that the innovators we serve value the progress we’re making toward that goal.”

This is Thermo Fisher’s ninth straight year being recognized by the CMO Leadership Awards, which distinguish top contract manufacturing organizations each year by surveying leading global pharma and biotech companies. That research, based on the Contract Manufacturing Quality Benchmarking conducted by Industry Standard Research (ISR), involved customers of all sizes that worked with the organizations during the past 18 months.

“For nearly a decade, the CMO Leadership Awards have recognized our industry’s top service providers – CDMOs that have remained steadfast partners to pharma and biopharma companies,” said Louis Garguilo, Chief Editor, Outsourced Pharma. “These awards have proven most meaningful for biopharma organizations striving to obtain optimal outcomes from their outsourcing activities. Our research arm, Industry Standard Research (ISR), which only surveys drug sponsors who have worked recently with specific CDMOs, ensures the validity of these results.”

To learn more about the CMO Leadership Awards, please visit https://www.cmoleadershipawards.com/.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

About the CMO Leadership Awards

Now in its 11th year, Outsourced Pharma and Life Science Leader's CMO Leadership Awards provide readers with accurate and reliable customer feedback to assist them in choosing a reputable partner for their development and manufacturing needs. For the 2022 CMO Leadership Awards, Industry Standard Research (ISR) determined the award recipients through their evaluation of more than 86 contract manufacturers. These CMOs were assessed by 23 performance metrics in ISR's annual Contract Manufacturing Quality Benchmarking survey. For more information about the awards, visit the awards website.

Contacts

Erin Morton
Thermo Fisher Scientific
+1 352.554.1441
erin.morton@thermofisher.com

Joanne Stanway
Greenough
+1 978.273.1473
jstanway@greenough.biz

 

Thermo Fisher

NYSE:TMO
Details
Headquarters: Waltham, Massachusetts
CEO: Marc N. Casper
Employees: 100,000
Organization: PUB
Revenues: $40 Billion (2021)

Release Versions

Contacts

Erin Morton
Thermo Fisher Scientific
+1 352.554.1441
erin.morton@thermofisher.com

Joanne Stanway
Greenough
+1 978.273.1473
jstanway@greenough.biz

 

More News From Thermo Fisher

Thermo Fisher Scientific Announces Quarterly Dividend

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.47 per common share, payable on July 15, 2026, to shareholders of record as of June 15, 2026. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our Mission is to enable our customers to make the world healthier...

Thermo Fisher Scientific Highlights Industry Leadership, Growth Outlook and Long-Term Value Creation at 2026 Investor Day

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, hosted its Investor Day today. Chairman and Chief Executive Officer Marc N. Casper and members of the senior leadership team highlighted the company’s industry leadership and the essential role of its best-in-class products and services to customers around the world. "Our customers value Thermo Fisher as their trusted partner,” said Marc N. Casper, chairman and chief executive office...

Thermo Fisher Scientific’s PPD Clinical Research Business Expands Bioanalytical Capabilities with New Laboratory in Gothenburg, Sweden

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced the opening of a new bioanalytical and biomarker laboratory in Gothenburg, Sweden, located within GoCo Health Innovation City. This new facility expands the company’s global bioanalytical capabilities to support pharmaceutical and biotechnology customers across all phases of drug development. With state-of-the-art instrumentation and Good Laboratory Practice (GLP) capabilities, the la...
Back to Newsroom